European Pharmaceutical Manufacturer explores the rise of ketamine as treatment for depression and why a recent study shines hope on the drug being used to treat alcohol use disorder.
A study published in January in the American Journal of Psychiatry has pointed to the use of ketamine as a treatment for people with alcohol use disorder (AUD). The study was labelled as the first of its kind to investigate how ketamine-assisted therapy can treat AUD and the results were positive.
Of the results available, perhaps the most significant is the fact that without treatment, one in eight patients would have died. Following treatment, that number decreased to one in 80, representing a 10-fold decrease in the risk of mortality.